$2.82
-0.09-3.09%
Pre-Market: Dec 24, 1:56 PM EDT
Leap Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Leap Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-13 | $-0.44 | $-0.48 | 8.33 % |
Jun 2024 | 2024-08-12 | $-0.52 | $-0.43 | -20.9 % |
Mar 2024 | 2024-05-13 | $-0.51 | $-0.58 | 12.1 % |
Dec 2023 | 2024-03-18 | $-0.46 | $-0.55 | 16.4 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Dec 2022 | 2023-03-24 | $0 | $1.20M | -100.0 % |
Jun 2022 | 2022-08-12 | $0 | $80.00K | -100.0 % |
Dec 2021 | 2022-03-11 | $375.00K | $310.00K | 21.0 % |
Sep 2021 | 2021-11-12 | $375.00K | $1.51M | -75.2 % |
Leap Therapeutics (LPTX) is scheduled to report earnings on March 17, 2025. The last reported earnings were for reported on November 13, 2024 for Q3.
The Actual EPS was $-0.44, which beat the estimate of $-0.48.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.